


About Primera Genotech
Pioneering AAV Innovation in Gene Therapy
Primera Genotech, LLC is an innovative biotechnology service company dedicated to advancing gene therapy through novel Adeno-Associated Virus (AAV) R&D platforms and expert services, from construct design to production. Serving biotechnology, pharmaceutical, and academic clients, we deliver tailored solutions that accelerate research and drive scientific breakthroughs.
With state-of-the-art laboratories in Pennsylvania and North Carolina and highly experienced teams, we are committed to quality, innovation, and client success.
Cutting-edge AAV Platforms
Custom-developed AAV solutions designed for research and clinical applications.
Dedicated Services
Comprehensive support for gene therapy, including consulting and technical guidance.
Our Leadership Team
Primera Genotech’s leadership team brings together decades of experience in biotechnology, gene therapy, and laboratory management. United by a passion for innovation, our experts are dedicated to delivering outstanding results for our clients.
Our Chief Executive Officer and Chief Scientific Officer: Xiangyang (Peter) Zhou, Ph.D.
Chief Operating Officer: Bingbing Feng, Ph.D.
Chief Manufacturing Officer: Stephen Soltys, M.S.
Director of Research and Development: Zhong Deng, Ph.D.
Cutting Edge Platforms
We have developed proprietary large capacity of AAV with hybrid ITRs and method for generating AAVs of different serotypes.
For product purification, we developed buffer systems (patent pending) for lysis, affinity, elution and ion exchange to achieve optimal separation and collection of full particles without using enzymes.
★★★★★
The team’s technical knowledge and support are unmatched in the industry.

Dr. J. Rabinowitz
Industry Partner
★★★★★
Their collaborative approach and commitment to quality make them a valued partner.

Prof. G. Gao
Academic Collaborator
Advance Your Research with Primera Genotech
Contact our team to discuss your project or explore our AAV solutions and specialized proprietary products.
